177 related articles for article (PubMed ID: 31582539)
21. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
22. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
[TBL] [Abstract][Full Text] [Related]
24. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress.
Asparuhova MB; Ferralli J; Chiquet M; Chiquet-Ehrismann R
FASEB J; 2011 Oct; 25(10):3477-88. PubMed ID: 21705668
[TBL] [Abstract][Full Text] [Related]
25. [Factors involved in host-pathogen interaction for the risk of Hodgkin lymphoma induced by Epstein Barr virus].
Torres Espíndola LM; Arellano Galindo J; Velazquez Cruz R; Castillejos López Mde J
Invest Clin; 2013 Sep; 54(3):311-24. PubMed ID: 24354244
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
Siegler G; Kremmer E; Gonnella R; Niedobitek G
Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
[TBL] [Abstract][Full Text] [Related]
27. Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.
Gandhi MK; Moll G; Smith C; Dua U; Lambley E; Ramuz O; Gill D; Marlton P; Seymour JF; Khanna R
Blood; 2007 Aug; 110(4):1326-9. PubMed ID: 17438085
[TBL] [Abstract][Full Text] [Related]
28. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated lymphoproliferative disorders.
Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
[TBL] [Abstract][Full Text] [Related]
30. Identification, expression and characterization of rat isoforms of the serum response factor (SRF) coactivator MKL1.
Ishikawa M; Shiota J; Ishibashi Y; Hakamata T; Shoji S; Fukuchi M; Tsuda M; Shirao T; Sekino Y; Ohtsuka T; Baraban JM; Tabuchi A
FEBS Open Bio; 2013; 3():387-93. PubMed ID: 24251100
[TBL] [Abstract][Full Text] [Related]
31. Injury induced expression of caveolar proteins in human kidney tubules - role of megakaryoblastic leukemia 1.
Krawczyk KM; Hansson J; Nilsson H; Krawczyk KK; Swärd K; Johansson ME
BMC Nephrol; 2017 Oct; 18(1):320. PubMed ID: 29065889
[TBL] [Abstract][Full Text] [Related]
32. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
33. Hodgkin Lymphoma Monozygotic Triplets Reveal Divergences in DNA Methylation Signatures.
Xia C; Olsen TK; Zirakzadeh AA; Almamoun R; Sjöholm LK; Dahlström J; Sjöberg J; Claesson HE; Johnsen JI; Winqvist O; Xu D; Ekström TJ; Björkholm M; Strååt K
Front Oncol; 2020; 10():598872. PubMed ID: 33363029
[TBL] [Abstract][Full Text] [Related]
34. The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1.
Cader FZ; Vockerodt M; Bose S; Nagy E; Brundler MA; Kearns P; Murray PG
Blood; 2013 Dec; 122(26):4237-45. PubMed ID: 24136166
[TBL] [Abstract][Full Text] [Related]
35. MKL1 deficiency results in a severe neutrophil motility defect due to impaired actin polymerization.
Sprenkeler EGG; Henriet SSV; Tool ATJ; Kreft IC; van der Bijl I; Aarts CEM; van Houdt M; Verkuijlen PJJH; van Aerde K; Jaspers G; van Heijst A; Koole W; Gardeitchik T; Geissler J; de Boer M; Tol S; Bruggeman CW; van Alphen FPJ; Verhagen HJMP; van den Akker E; Janssen H; van Bruggen R; van den Berg TK; Liem KD; Kuijpers TW
Blood; 2020 Jun; 135(24):2171-2181. PubMed ID: 32128589
[TBL] [Abstract][Full Text] [Related]
36. A fulminant case of classical Hodgkin lymphoma: A diagnostic dilemma of Epstein-Barr virus-positive large B-cell neoplasms.
Ichimata S; Kobayashi M; Ohya M; Otsuki T; Yanagisawa K; Tateishi K; Kato A; Matsuo A; Kanno H
Pathol Int; 2019 Jul; 69(7):407-413. PubMed ID: 31215109
[TBL] [Abstract][Full Text] [Related]
37. LncRNA HOTAIR promotes cell migration and invasion by regulating MKL1 via inhibition miR206 expression in HeLa cells.
Zheng P; Yin Z; Wu Y; Xu Y; Luo Y; Zhang TC
Cell Commun Signal; 2018 Feb; 16(1):5. PubMed ID: 29391067
[TBL] [Abstract][Full Text] [Related]
38. Divergent Regulation of Actin Dynamics and Megakaryoblastic Leukemia-1 and -2 (Mkl1/2) by cAMP in Endothelial and Smooth Muscle Cells.
Smith MC; Hudson CA; Kimura TE; White SJ; Sala-Newby GB; Newby AC; Bond M
Sci Rep; 2017 Jun; 7(1):3681. PubMed ID: 28623279
[TBL] [Abstract][Full Text] [Related]
39. MKL1 mediates TGF-beta1-induced alpha-smooth muscle actin expression in human renal epithelial cells.
Elberg G; Chen L; Elberg D; Chan MD; Logan CJ; Turman MA
Am J Physiol Renal Physiol; 2008 May; 294(5):F1116-28. PubMed ID: 18337547
[TBL] [Abstract][Full Text] [Related]
40. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
